AWM
IBB icon

Aberdeen Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Aberdeen Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3K Hold
120
– – 0.01% 164
2025
Q4 		$20.3K Hold
120
– – 0.01% 164
2025
Q3 		$17.3K Hold
120
– – 0.01% 154
2025
Q2 		$15.2K Hold
120
– – 0.01% 154
2025
Q1 		$15.3K Hold
120
– – 0.01% 149
2024
Q4 		$15.9K Sell
120
-17
-12% -$2.39K 0.01% 155
2024
Q3 		$19.9K Sell
137
-400
-74% -$57.9K 0.01% 158
2024
Q2 		$73.7K Buy
537
+17
+3% +$2.27K 0.05% 150
2024
Q1 		$71.4K Buy
520
+400
+333% +$54.6K 0.04% 153
2023
Q4 		$16.3K Sell
120
-400
-77% -$48.8K 0.01% 153
2023
Q3 		$63.6K Hold
520
– – 0.05% 145
2023
Q2 		$66K Hold
520
– – 0.05% 144
2023
Q1 		$67.2K Hold
520
– – 0.05% 146
2022
Q4 		$68.3K Hold
520
– – 0.05% 146
2022
Q3 		$61K Hold
520
– – 0.05% 140
2022
Q2 		$61K Hold
520
– – 0.05% 144
2022
Q1 		$68K Hold
520
– – 0.05% 149
2021
Q4 		$79K Buy
+520
New +$80.5K 0.05% 146
2021
Q2 		– Sell
-520
Closed -$78K – 133
2021
Q1 		$78K Hold
520
– – 0.06% 133
2020
Q4 		$79K Sell
520
-17
-3% -$2.43K 0.06% 139
2020
Q3 		$73K Buy
+537
New +$72.9K 0.07% 123
2020
Q2 		– Sell
-17
Closed -$2K – 131
2020
Q1 		$2K Buy
+17
New +$1.96K ﹤0.01% 119

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Aberdeen Wealth Management's IBB Position: Q1 2026 in Review

Aberdeen Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 120 shares worth $20.3K. The position accounts for 0.01% of the portfolio, ranked #164.

Aberdeen Wealth Management first reported a position in IBB in Q1 2020 and has held it in 22 quarters since. The position peaked at $79K in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Aberdeen Wealth Management held 120 shares of iShares Biotechnology ETF worth $20.3K as of Q1 2026.
  • Aberdeen Wealth Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.01% of Aberdeen Wealth Management's portfolio in Q1 2026, its #164 holding.
  • Aberdeen Wealth Management first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 22 quarters since.
  • Aberdeen Wealth Management's iShares Biotechnology ETF position peaked at $79K in Q4 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Aberdeen Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.